Skip to main content

Pinnacle-Hip Lawsuit - J&J Agrees To Pay $1 Billion

Pinnacle-Hip Lawsuit - J&J Agrees To Pay $1 Billion

Pinnacle-Hip Lawsuit - J&J Agrees To Pay $1 Billion

Introduction

Johnson & Johnson has agreed to pay $1 billion to resolve claims involving personal injury linked to the usage of a metal-on-metal version of DePuy Orthopaedics.

There are around 10,000 Depuy Pinnacle hip lawsuits that are currently pending in multidistrict litigation centralized in U.S. District Court, Northern District of Texas. As per the recent agreement with Texas juries, more than 95 percent of the 6,000 cases have been resolved. J&J agreed to pay $120 million last February to settle 46 state attorneys generals’ allegations linked to ambiguous claims about the hips’ durability. In November 2013, the company had announced a $2.5 billion settlement to resolve 93,000 claims filed in connection with the DePuy ASR hip recall. The sales of metal Ultamet liner ended in May 2013, after regulatory restrictions by U.S. Food & Drug Administration. However,  the sales of Pinnacle hips made from other materials were not affected.

The Pinnacle lawsuits are centralized under MDL 3:11-MD-02244, In Re: DePuy Orthopaedics, Inc., Pinnacle Hip Implant Products Liability Litigation, U.S District Court, Northern District of Texas (Dallas). Similar lawsuits are filed against other hip device manufacturers in the U.S. involving defendants Zimmer, Stryker, Biomet, Wright, and Smith & Nephew.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Baltimore Wins $266M in Opioid Case Against Drug Distributors

Categories: Opioids

Baltimore has secured a $266 million victory in its lawsuit against major drug distributors McKesson and Cencora (formerly AmerisourceBergen), accusing them of fueling the…

DOJ Opposes JnJ’s Texas Bankruptcy Move in Talc Lawsuit Cases

Categories: Talcum

The U.S. Department of Justice (DOJ) recently opposed Johnson & Johnson’s latest attempt to use bankruptcy to resolve tens of thousands of…

First Valsartan Bellwether Trial to Focus on Cancer Lawsuits

Categories: Valsartan

The U.S. District Judge overseeing…

Demand Letter or Medical Record Review?     
Free Trials + 10% Discount!